Intelligence · Clinical Pipeline
Rhythm Pharmaceuticals Netherlands Pipeline
All ClinicalTrials.gov programs at Rhythm Pharmaceuticals Netherlands — phase, modality, and trial IDs.
- Programs
- 13
Quick answer
Rhythm Pharmaceuticals Netherlands has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Bivamelagon
Rhythm Pharmaceuticals Netherlands B.V.
Hypothalamic Obesity
1 trial -
Diuretics
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
LB54640
Rhythm Pharmaceuticals Netherlands B.V.
Hypothalamic Obesity
1 trial -
Medtronic PrimeADVANCED Neurostimulator
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
PCI
Rhythm Pharmaceuticals Netherlands B.V.
Myocardial Infarction
1 trial -
Part A: RM-718 or placebo (matched to specific RM-718 dose cohort)
Rhythm Pharmaceuticals Netherlands B.V.
Hypothalamic Obesity
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Genetic Obesity
2 trials -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Hypertriglyceridemia
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Overweight
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Overweight and Obesity
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Prader-Willi Syndrome
2 trials -
Single Site Pacing
Rhythm Pharmaceuticals Netherlands B.V.
Acute Myocardial Infarction
1 trial -
Tideglusib
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmogenic Cardiomyopathy
1 trial
Frequently asked questions
How many pipeline programs does Rhythm Pharmaceuticals Netherlands have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs